Literature DB >> 21877887

Understanding and mitigating impact of immunogenicity on pharmacokinetic assays.

Joleen T White, Michaela Golob, Jeffrey Sailstad.   

Abstract

Mesh：

Year:  2011        PMID： 21877887     DOI： 10.4155/bio.11.162

Source DB:  PubMed          Journal:  Bioanalysis        ISSN： 1757-6180            Impact factor:   2.681


× No keyword cloud information.
  2 in total

1.  Impact of anti-drug antibodies in preclinical pharmacokinetic assessment.

Authors:  Theingi M Thway; Ivan Magana; Ami Bautista; Vibha Jawa; Wen Gu; Mark Ma
Journal:  AAPS J       Date:  2013-05-08       Impact factor: 4.009

Review 2.  A white paper--consensus and recommendations of a global harmonization team on assessing the impact of immunogenicity on pharmacokinetic measurements.

Authors:  J M Sailstad; L Amaravadi; A Clements-Egan; B Gorovits; H A Myler; R C Pillutla; S Pursuhothama; M Putman; M K Rose; K Sonehara; L Tang; J T Wustner
Journal:  AAPS J       Date:  2014-03-29       Impact factor: 4.009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.